These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 7527672

  • 1. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P, Spanblöchl E, Bankl HC, Sperr WR, Marosi C, Pirc-Danoewinata H, Virgolini I, Eichler HG, Agis H, Sillaber C.
    Blood; 1994 Dec 15; 84(12):4322-32. PubMed ID: 7527672
    [Abstract] [Full Text] [Related]

  • 2. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM, Williams DE, Fibbe WE, Wessels HW, Beverstock GC, Willemze R, Falkenburg JH.
    Blood; 1992 Aug 01; 80(3):750-7. PubMed ID: 1638026
    [Abstract] [Full Text] [Related]

  • 3. Development of tryptase-positive KU812 cells cultured in the presence of Steel factor.
    Saito H, Miura K, Takahashi G, Ebisawa M, Matsumoto K, Shichijo M, Onda T, Iikura Y, Yanagihara Y, Ra C.
    Int Arch Allergy Immunol; 1995 Aug 01; 107(1-3):330-2. PubMed ID: 7542083
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, Bennett JM.
    Leuk Res; 2001 Jul 01; 25(7):595-602. PubMed ID: 11377685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
    Siitonen T, Savolainen ER, Koistinen P.
    Leukemia; 1994 Apr 01; 8(4):631-7. PubMed ID: 7512174
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells.
    Brizzi MF, Blechman JM, Cavalloni G, Givol D, Yarden Y, Pegoraro L.
    Oncogene; 1994 Jun 01; 9(6):1583-9. PubMed ID: 7514283
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
    Horny HP, Valent P.
    Leuk Res; 2001 Jul 01; 25(7):543-51. PubMed ID: 11377679
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
    Schneeweiss M, Peter B, Bibi S, Eisenwort G, Smiljkovic D, Blatt K, Jawhar M, Berger D, Stefanzl G, Herndlhofer S, Greiner G, Hoermann G, Hadzijusufovic E, Gleixner KV, Bettelheim P, Geissler K, Sperr WR, Reiter A, Arock M, Valent P.
    Haematologica; 2018 May 01; 103(5):799-809. PubMed ID: 29439183
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.